CIK 0001411685
- Non-accelerated filer
- Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 205093315
- Phone
- +1 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- 4 Gift CHIEF OPERATING OFFICER gave 235,000 shares (gift)
- 4 Other disposition 10% owner disposed of 484,000 shares (other)
- 4 Option exercise PRES./CHIEF SCIENTIFIC OFFICER acquired 113,636 shares (option exercise)
- 4 Option exercise Director acquired 2,784 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale PRESIDENT sold 4,982,103 shares
- 4 Grant or award Director acquired 17,354 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 229,521 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award PRES./CHIEF SCIENTIFIC OFFICER acquired 545,416 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 76,087 shares (grant or award)
Page 14 of 15 · 282 filings